Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 20, 2020.
Sinovac is working on one of the more closely watched candidate vaccines for the disease, but trading of its shares has been long suspended.
In this episode, we break down Moderna's early-stage results from a coronavirus vaccine and the reaction from unsatisfied experts around the globe.
The Rentschler Biopharma and Horizon Discovery agreement is designed to enhance Rentschler’s in-house process for difficult-to-express proteins.
The desperate hunt for treatments and vaccines has changed how researchers, regulators, drug companies like Moderna, investors and journalists do their jobs.
BEIJING – Androgen receptor (AR)-related disease specialist Kintor Pharmaceutical Ltd., of Suzhou, China, raised $240 million on the Hong Kong Stock Exchange (HKEX) on May 22 by issuing ...